PacBio designates the Global Institute for Food Security as Canada’s first Revio Certified Service Provider, enhancing genomics access.
Quiver AI Summary
PacBio has announced that the Global Institute for Food Security (GIFS) at the University of Saskatchewan has become Canada’s first Revio PacBio Certified Service Provider. GIFS will provide access to PacBio's HiFi sequencing technology, allowing researchers to conduct advanced genetic studies with high accuracy. This partnership aims to support research initiatives in areas such as agricultural innovation and disease discovery. PacBio's certification recognizes GIFS's expertise and infrastructure to deliver top-quality sequencing services. The OMICS and Precision Analytics Laboratory at GIFS will offer comprehensive genomics solutions, including bioinformatics support, enhancing the capabilities available to researchers tackling significant challenges in food security and sustainability.
Potential Positives
- PacBio has established a significant partnership with the Global Institute for Food Security, enhancing its visibility and credibility in the genomics research community in Canada.
- The certification of GIFS as the first Revio PacBio Certified Service Provider in Canada will increase access to PacBio's advanced HiFi sequencing technology for researchers, potentially leading to more collaborative projects and innovations.
- This partnership aligns with PacBio's commitment to addressing global challenges such as food security, agricultural sustainability, and precision health through advanced sequencing solutions.
- The integration of PacBio technology into GIFS's OPAL platform positions both organizations to deliver high-quality sequencing data and critical analyses, supporting large-scale genomic projects effectively.
Potential Negatives
- Inclusion of a forward-looking statement disclaimer highlights potential uncertainties and risks associated with the use of PacBio products, which could undermine investor confidence.
- Emphasis on potential performance and regulatory issues suggests vulnerabilities in the technology, which may deter researchers from fully relying on PacBio's offerings.
- The phrase "Research Use Only. Not for use in diagnostic procedures" limits the applicability of their products, which might hinder market expansion opportunities.
FAQ
What is the significance of GIFS becoming a PacBio Certified Service Provider?
The certification allows GIFS to provide access to PacBio’s advanced HiFi sequencing technology to researchers in Canada and globally.
How does PacBio's HiFi sequencing technology benefit researchers?
HiFi sequencing technology enhances the accuracy and quality of long-read sequencing data, facilitating complex genetic studies and applications.
What services does GIFS offer through its OPAL platform?
GIFS provides full-service genomics solutions, including automation, bioinformatics, and advanced data analysis for large-scale genomic projects.
Why is precision health important in agriculture?
Precision health in agriculture helps address challenges related to food security and sustainability, improving production methods and crop resilience.
Where can I learn more about PacBio's sequencing solutions?
For more information about PacBio’s products and technologies, visit their website at www.pacb.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$PACB Insider Trading Activity
$PACB insiders have traded $PACB stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $PACB stock by insiders over the last 6 months:
- CHRISTIAN O HENRY (See Remarks) sold 98,907 shares for an estimated $172,691
- OENE MARK VAN (See Remarks) has made 0 purchases and 2 sales selling 72,416 shares for an estimated $133,154.
- JEFF EIDEL (See Remarks) sold 26,760 shares for an estimated $42,601
- SUSAN G. KIM (See Remarks) sold 19,782 shares for an estimated $34,064
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PACB Hedge Fund Activity
We have seen 87 institutional investors add shares of $PACB stock to their portfolio, and 101 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC removed 8,356,139 shares (-32.1%) from their portfolio in Q3 2024, for an estimated $14,205,436
- MILLENNIUM MANAGEMENT LLC added 5,792,951 shares (+125.1%) to their portfolio in Q3 2024, for an estimated $9,848,016
- BANK OF NEW YORK MELLON CORP removed 4,362,004 shares (-43.9%) from their portfolio in Q3 2024, for an estimated $7,415,406
- EDMOND DE ROTHSCHILD HOLDING S.A. added 3,571,460 shares (+21.3%) to their portfolio in Q3 2024, for an estimated $6,071,482
- JACKSON SQUARE PARTNERS, LLC removed 2,587,327 shares (-29.1%) from their portfolio in Q3 2024, for an estimated $4,398,455
- D. E. SHAW & CO., INC. removed 1,645,499 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $2,797,348
- VK SERVICES, LLC removed 1,316,391 shares (-50.0%) from their portfolio in Q3 2024, for an estimated $2,237,864
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
MENLO PARK, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Global Institute for Food Security (GIFS) at the University of Saskatchewan (USask) as the first Revio PacBio Certified Service Provider (CSP) in Canada.
Known for its leadership in animal, microbial and plant genomics, GIFS offers PacBio’s HiFi sequencing technology through its Omics and Precision Analytics Laboratory (OPAL) platform. This provides researchers across Canada and around the world with access to highly accurate long-read sequencing data to support complex genetic studies and practical applications, from agricultural innovation to disease discovery.
The PacBio Certified Service Provider program ensures that customers worldwide have access to the highest quality sequencing services powered by PacBio technology. By achieving CSP status, GIFS has demonstrated the capability, expertise, and infrastructure required to deliver high-quality PacBio sequencing solutions, including complex genome assemblies, transcriptomics, epigenetics, and other precision applications.
“Canada is home to a dynamic genomics research community that plays a key role in addressing global challenges such as food security, agricultural sustainability, and precision health,” said James Hudson, Senior Director of Americas Sales at PacBio. “We are proud to welcome GIFS as Canada’s first Revio PacBio Certified Service Provider. This certification provides Canadian researchers access to PacBio’s highly accurate HiFi sequencing technology through a trusted partner, enabling them to generate critical insights with exceptional precision and quality.”
GIFS’ OPAL platform provides full-service genomics solutions that include automation, bioinformatics, and advanced data analysis, positioning them as a valuable resource for researchers looking to tackle large-scale genomic projects. Through PacBio’s HiFi sequencing technology, GIFS will empower scientists to address emerging challenges.
“The Global Institute for Food Security’s world-class technology platforms help researchers and organizations to scale and accelerate their research and development. As a PacBio Certified Service Provider, our partners know they can depend on GIFS to deliver high-quality, HiFi data to advance their projects,” said Dr. Steven Webb (PhD), GIFS CEO. “Today, GIFS’ Omics and Precision Analytics Laboratory uses high-throughput automated workflows to help our partners get the most from PacBio’s long-read sequencing technologies. The sequencing results we deliver are supported by GIFS’ automated bioinformatics and visualizations pipelines, ensuring our partners receive both high-quality data and critical analysis that can help them to discover, develop, and deliver.”
For more on the comprehensive services that GIFS provides, see
gifs.ca/partners
.
The addition of GIFS to PacBio’s growing Certified Service Provider network highlights PacBio’s commitment to making its advanced sequencing solutions accessible to researchers worldwide.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our HiFi long-read sequencing and our SBB
®
short-read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit
www.pacb.com
and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
About the Global Institute for Food Security at the University of Saskatchewan
The Global Institute for Food Security (GIFS) at the University of Saskatchewan (USask) works with partners to discover, develop, and deliver innovative solutions for the production of globally sustainable food. Serving as ‘agriculture’s innovation catalyst,’ GIFS is connecting the agri-food ecosystem, advancing innovation, and bridging the gap to commercialization to deliver resilient and sustainable food security for all stakeholders. For more information, visit
gifs.ca
.
Forward Looking Statements
This press release may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including statements relating to the uses, coverage, advantages, and benefits or expected benefits of using, PacBio products or technologies, including the ability of GIFS to deliver high-quality sequencing solutions; enabling researchers to generate critical insights and address emerging challenges using PacBio technology through GIFS; and other future events. You should not place undue reliance on forward-looking statements because they are subject to assumptions, risks, and uncertainties and could cause actual outcomes and results to differ materially from currently anticipated results, including, the difficulty of generating discoveries in complicated areas of biology; potential performance, quality and regulatory issues; and third-party claims alleging infringement of patents and proprietary rights or seeking to invalidate PacBio's patents or proprietary rights. Additional factors that could materially affect actual results can be found in PacBio's most recent filings with the Securities and Exchange Commission, including PacBio's most recent reports on Forms 8-K, 10-K, and 10-Q, and include those listed under the caption "Risk Factors." These forward-looking statements are based on current expectations and speak only as of the date hereof; except as required by law, PacBio disclaims any obligation to revise or update these forward-looking statements to reflect events or circumstances in the future, even if new information becomes available.
Contacts:
PacBio
For investors:
Todd Friedman,
IR@pacificbiosciences.com
For media:
PR@pacificbiosciences.com
Global Institute for Food Security:
Communications:
Dan Yates,
dan.yates@gifs.ca
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
